Nutrition and immunity in nontuberculous mycobacteria lung disease
Part of Infections, Lungs & breathing clinical trials.
This study looks at how nutrition and immune cell activity relate to the progression of lung disease caused by nontuberculous mycobacteria (NTM). It may help doctors better understand and monitor this chronic infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with or are suspected to have NTM lung disease
- You are scheduled for a bronchoscopy (a scope test of your airways) as part of your regular care
- You are not currently being treated for active tuberculosis (TB)
- You do not have active cancer, autoimmune disease, or a recent serious lung infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
This is a research registry that collects information from adults diagnosed with nontuberculous mycobacterial (NTM) lung disease. It may help doctors better understand the disease and improve care over time.
This study checks whether a blood test called soluble programmed death-1 can help predict how nodular-bronchiectatic nontuberculous mycobacterial (NTM) lung disease will progress. Results may help doctors monitor patients more accurately and decide when to treat or follow more closely.
This study will look at people with a lung infection called nontuberculous mycobacterial lung disease to find out more about how their immune system reacts. If you have this condition, your medical history and possibly a lung sample can help researchers understand why some people get sicker than others.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
Hear when a new Nontuberculous Mycobacterial Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.